Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone versus magnesium sulphate as adjuvants to bupivacaine for superficial cervical plexus block in thyroid surgery
PACTR202512516522906Phase 3Not yet recruiting
- Sponsor
- Assiut University
- Start
- Jan 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexamethasone, magnesium sulfate and bupivacaine in postoperative pain (2 arms), sponsored by Assiut University. Primary endpoint: Time to first request of rescue analgesia. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
dexamethasonemagnesium sulfatebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on PACTR202512516522906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202512516522906.